V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005078 | 280003334 | 1.58 | 44.1 | null | 2013-05-13 | 2013-05-14 | Mitomycin Intravesical | Y | N | 280028488 | GEMCITABINE |
| 280005079 | 280003335 | 1.77 | 91.4 | Palliative (P) | 2015-06-21 | 2015-06-22 | Doxorubicin + Olaratumab | N | N | 280028491 | CAPECITABINE |
| 280005080 | 280003335 | 1.86 | 101.5 | Palliative (P) | 2017-12-18 | 2018-01-15 | Capecitabine | N | N | 280028491 | HYDROXYCARBAMIDE |
| 280005081 | 280003336 | 1.76 | null | Adjuvant (A) | 2013-12-28 | 2014-01-21 | STS Rhabdomyosarcoma RMS 2005 IVA | N | Y | 280028493 | MITOMYCIN INTRAVESICULAR |
| 280005082 | 280003337 | 1.83 | null | null | null | 2017-04-02 | Paclitaxel 7 day | null | null | 280028494 | GEMCITABINE |
| 280005083 | 280003337 | 1.66 | 87.4 | Palliative (P) | null | 2013-05-31 | VAC | N | N | 280028494 | ECX |
| 280005084 | 280003338 | null | null | null | 2017-01-16 | 2017-01-18 | OCTREOTIDE | N | null | 280028496 | GEMCARBO |
| 280005085 | 280007733 | null | 82 | Disease modification (D) | 2016-10-18 | 2016-10-21 | Ipilimumab | N | N | 280028499 | IRINOTECAN + MDG |
| 280005086 | 280009947 | null | 68.1 | Palliative (P) | 2015-01-04 | 2015-01-07 | Oxaliplatin + Modified de Gramont | 02 | Y | 280028500 | CAPECITABINE + CISPLATIN |
| 280005087 | 280009947 | 1.85 | 62.4 | Disease modification (D) | 2015-01-24 | 2015-02-15 | Paclitaxel 7 day | N | N | 280028500 | CAPECITABINE + OXALIPLATIN |
| 280005088 | 280003339 | 1.86 | 81.7 | null | null | 2016-12-02 | IVADo | Y | null | 280028502 | PEMBROLIZUMAB |
| 280005089 | 280003339 | 1.72 | 71.2 | Palliative (P) | 2016-12-01 | 2016-12-18 | Trabectedin | N | N | 280028502 | PEMBROLIZUMAB |
| 280005090 | 280003339 | 1.81 | 86 | Palliative (P) | 2015-09-08 | 2015-09-08 | Doxorubicin + Olaratumab | N | N | 280028502 | AFLIBERCEPT + FU + IRINOTECAN |
| 280005091 | 280003340 | 1.93 | 80.9 | Palliative (P) | 2017-08-07 | 2017-08-07 | GemCarbo Days 1+8 | 2 | N | 280028510 | LANREOTIDE |
| 280005092 | 280003340 | 1.74 | 83 | Palliative (P) | 2013-04-05 | 2013-04-05 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280028510 | CISPLATIN + PEMETREXED |
| 280005093 | 280003341 | 1.61 | null | Palliative (P) | 2014-01-27 | 2014-01-28 | LIPOSOMAL DOXORUBICIN | 2 | N | 280028512 | ECX |
| 280005094 | 280003341 | 1.54 | null | Palliative (P) | null | 2018-10-09 | Docetaxel + Gemcitabine with GCSF | null | null | 280028512 | CARBOPLATIN + PEMETREXED |
| 280005095 | 280003342 | null | 71.2 | Palliative (P) | 2015-11-05 | 2016-06-17 | CAPECITABINE + OXALIPLATIN | 02 | N | 280028516 | GEMCITABINE |
| 280005096 | 280007737 | 1.86 | 61.4 | Palliative (P) | 2015-03-07 | 2015-03-07 | LIPOSOMAL DOXORUBICIN | 02 | N | 280028519 | OXALIPLATIN + MDG |
| 280005097 | 280003343 | 1.65 | 100.4 | Palliative (P) | 2017-04-28 | 2017-05-15 | Paclitaxel 80mg/m2 day 1 8 15 | 2 | N | 280028520 | GEMCITABINE |
| 280005098 | 280003344 | 1.46 | 66.4 | Palliative (P) | 2016-07-01 | 2016-07-01 | Oxaliplatin + Modified de Gramont | N | N | 280028522 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 280005099 | 280003344 | 1.46 | 47.2 | Palliative (P) | 2018-01-05 | 2018-01-09 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | 02 | N | 280028522 | Y-90 |
| 280005100 | 280003345 | 1.88 | null | Palliative (P) | 2017-08-21 | 2017-08-28 | STS Rhabdomyosarcoma RMS 2005 IVADo | Y | N | 280028524 | ECX |
| 280005101 | 280003345 | null | 93.5 | Palliative (P) | 2014-11-15 | 2014-11-22 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280028524 | IRINOTECAN + MDG |
| 280005102 | 280003346 | 1.51 | 64 | Palliative (P) | 2016-06-01 | 2016-06-14 | Carboplatin + Pemetrexed | 2 | null | 280028530 | GEMCITABINE |
| 280005103 | 280003347 | 1.83 | 88 | Palliative (P) | 2014-06-17 | 2014-06-19 | Cisplatin + Pemetrexed | 01 | N | 280028531 | OXALIPLATIN + MDG |
| 280005104 | 280007740 | 1.56 | 87.9 | Palliative (P) | 2014-08-01 | 2014-08-19 | OCTREOTIDE | 2 | N | 280028532 | CARBOPLATIN + PEMETREXED |
| 280005105 | 280007740 | 1.71 | 52.2 | Palliative (P) | 2016-01-10 | 2016-01-11 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280028532 | CAPECITABINE |
| 280005106 | 280003348 | 0 | 60 | Not known (9) | 2016-04-05 | 2016-11-17 | ECX | 2 | N | 280028534 | TEMOZOLOMIDE |
| 280005107 | 280003348 | 1.79 | 62.2 | Palliative (P) | 2013-07-21 | 2013-07-21 | Cisplatin + Etoposide po&iv 3 day | N | N | 280028534 | ECARBOX |
| 280005108 | 280003348 | 1.75 | 87.4 | Palliative (P) | 2014-11-30 | 2014-12-15 | Doxorubicin + Olaratumab | 02 | N | 280028534 | IRINOTECAN + MDG |
| 280005109 | 280003349 | 1.95 | null | null | 2015-06-20 | 2015-06-26 | FLUOROURACIL + MITOMYCIN + RT | N | N | 280028541 | ECF |
| 280005110 | 280003349 | 1.81 | 77.25 | Neo-adjuvant (N) | null | 2017-10-11 | Mitomycin Intravesical | null | null | 280028541 | DACARBAZINE |
| 280005111 | 280003349 | 1.74 | 90 | Disease modification (D) | 2013-09-25 | 2013-09-25 | CARBOPLATIN + GEMCITABINE | 2 | N | 280028541 | LANREOTIDE |
| 280005112 | 280003350 | 1.66 | null | null | 2015-09-25 | 2015-09-28 | Cisplatin + Fluorouracil + RT 5day | N | N | 280028545 | VEMURAFENIB |
| 280005113 | 280003350 | 1.76 | 78.6 | Palliative (P) | 2017-06-22 | 2017-07-03 | Pazopanib | 02 | Y | 280028545 | BEVACIZUMAB + CAPE + OXALIPLATIN |
| 280005114 | 280003350 | null | null | Palliative (P) | 2017-05-21 | 2017-06-17 | DE-ESCALATE TRIAL | N | Y | 280028545 | OXALIPLATIN + MDG |
| 280005115 | 280003351 | 1.65 | 109.9 | Palliative (P) | 2016-03-15 | 2016-03-16 | FEC + DOCETAXEL | 02 | null | 280028551 | CARBOPLATIN + DOCETAXEL |
| 280005116 | 280003351 | 1.61 | 64 | Not known (9) | 2015-11-25 | 2015-12-15 | ARISTOTLE TRIAL | N | N | 280028551 | CARBOPLATIN + PEMETREXED |
| 280005117 | 280003351 | 1.8 | 66 | Palliative (P) | 2017-08-29 | 2017-08-29 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 280028551 | GEMCITABINE |
| 280005118 | 280003351 | 1.76 | 77 | Palliative (P) | 2016-06-22 | 2016-06-27 | Irinotecan + Modified De Gramont | 02 | N | 280028551 | CISPLATIN + PEMETREXED |
| 280005119 | 280003352 | null | 80.7 | null | 2016-04-06 | 2016-04-07 | DE-ESCALATE TRIAL | Y | null | 280028560 | IRINOTECAN + MDG |
| 280005120 | 280003352 | 1.75 | 92.65 | Palliative (P) | 2015-11-14 | 2015-12-03 | Docetaxel | N | N | 280028560 | CAPECITABINE + OXALIPLATIN |
| 280005121 | 280003352 | 1.8 | null | Palliative (P) | 2018-03-10 | 2018-03-22 | Gemcitabine day 1&8 | N | null | 280028560 | CISPLATIN + ETOPOSIDE |
| 280005122 | 280003353 | 1.7 | 92 | Palliative (P) | 2013-12-06 | 2013-12-09 | LANREOTIDE | 2 | N | 280028566 | ECX |
| 280005123 | 280003353 | 1.63 | 50.1 | Palliative (P) | 2015-06-02 | 2015-06-13 | Cisplatin + Doxorubicin | N | N | 280028566 | ECX |
| 280005124 | 280009955 | 1.79 | 115 | null | 2013-11-27 | 2013-12-14 | Ipilimumab | N | N | 280028571 | CAPECITABINE + IRINOTECAN |
| 280005125 | 280009955 | 1.69 | 58 | Palliative (P) | 2016-11-04 | 2016-11-04 | Capecitabine | 01 | N | 280028571 | GEMCITABINE |
| 280005126 | 280009955 | 1.8 | 57.8 | Palliative (P) | 2016-05-25 | 2016-06-02 | DA 3 + 10 | 02 | N | 280028571 | CAPECITABINE + OXALIPLATIN |
| 280005127 | 280009955 | null | 56.9 | Neo-adjuvant (N) | 2014-08-11 | 2014-12-18 | Temozolomide + RT | N | null | 280028571 | OCTREOTIDE |